RSS   Newsletter   Contact   Advertise with us

VirMedica names John H. Johnson as executive chairman of the board

Staff writer | Philadelphia, Pa., USA | November 10, 2015
VirMedicaOctober 10, 2015, Philadelphia, Pa., USA - VirMedica, a holding company, announced the appointment of John H. Johnson as executive chairman of the company's board of directors.
Mr. Johnson is a recognized leader in the biopharmaceutical industry with more than 30 years of experience at leading global organizations, including Johnson & Johnson, Eli Lilly & Company, ImClone and Pfizer, Inc.

He currently serves as chairman of Strongbridge Biopharma plc, and as a member of the board of directors of Cempra Pharmaceuticals, Inc., Histogenics Corporation, Portola Pharmaceuticals, Inc., and Sucampo Pharmaceuticals, Inc.

Mr. Johnson previously served as a member of the board of directors of Pharmaceutical Research and Manufacturers of America (PhRMA), the Health Section Governing Board of Biotechnology Industry Organizations (BIO), and BioNJ.


 LATEST MOVES FROM Pennsylvania 


MORE INSIDE POST